Singapore: Apollo's Medical e-learning initiative, Medvarsity, has tied up with University of New South Wales (UNSW),to ...
Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...
Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with app...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...
Singapore: Institutional and retail investors of Bioxyne re-elected chairman Mr Ian Mutton and managing director Mr Dav...
Singapore: The US Agency for International Development (USAID) and the Australian Agency for International Development (...
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system that noninvasively measure...
Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access...
Singapore: Australian drug development company CBio will merge with US-based Inverseon in a deal to establish a clinical...
Singapore: Immunocore entered into a research collaboration and licensing agreement with Genentech, a member of the Roch...
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...
Singapore: Spinifex Pharmaceuticals announced that Dr Ronald Marcus would be the new Chief Medical Officer. He would be ...
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...
Singapore: Research from University of Adelaide have shown that immune cells known as macrophages are critical to fertil...
Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumati...
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...
Singapore: CardioCel, a cardiovascular tissue patch to repair heart deformities including repairing and reconstructing h...
Singapore: Australia-based medical device developer Aimedics, in consultation with Therapeutic Goods Administration (TGA...
Singapore: Benitec Biopharma and uniQure, a leader in the field of human gene therapy, announced a non-exclusive cross...
Singapore: The US Patent and Trademark Office (USPTO) has granted Unilife patent for the Unifill ready-to-fill (prefille...
Singapore: Japan-based Fujikura Kasei is going to licence cancer diagnostic antibody midkine (MK) developed by Australia...
China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which ...
Singapore: DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has launched its new cGMP ...
Singapore: Australian drug delivery technology company Phosphagenics has appointed US pharmaceutical consulting company,...
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...
Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Healt...
Singapore: TranScrip Partners, a UK-based contract service organization, has appointed Australia-based Dr Glen Pater. D...
Singapore: QRxPharma announced that the company resubmitted its Moxduo New Drug Application (NDA) to the US FDA. As dis...
Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...
Singapore: Phylogica licensed its anti-aging, skin-repair Phylomer peptide, PYC35, to Le Métier de Beauté for use ...
Singapore: Neopec has demonstrated proof-of-concept for breast tissue growth using its breast reconstruction chamber in ...
Singapore: Lignol Energy (LEC), a leading technology company in the advanced biofuels and renewable chemicals sector, ha...
Singapore: Eisai, a Japanese pharmaceutical company, is seeking to expand its global network by opening a new office in ...
Singapore: Australia-based Ellex Medical Lasers, medical technology developers for the diagnosis and treatment of eye di...
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has launched IMOJEV vaccine against Japanese encephalitis (J...
Singapore: Australian-based drug discovery and development company Alchemia has raised $10.44 million (A$10.2 million) ...
Singapore: Aquavit Life Sciences, a wholly owned subsidiary of Aquavit Pharmaceuticals, signed a memorandum of understa...
"Obstacles are those frightful things you see when you take your eyes off your goal." — Henry Ford I started my ...
Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSp...
Over the years, some of the Asian companies have made significant breakthroughs in antibody research and are exploring f...
Singapore: Australian biopharmaceutical company Imugene has appointed Dr Christoph Zielinski and Dr Ursula Wiedermann to...
Singapore: Living Cell Technologies have signed an agreement with Otsuka Pharmaceutical Factory to co-develop NTCELL for...
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...
Singapore: Victorian Minister for Technology, Mr. Gordon Rich-Phillips, has launched a Guide for Life Science Company Di...
Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...
Singapore: A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to...
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...
Singapore: AusBiotech calls on the Federal Government to provide some certainty to the innovation sector as support pro...
Singapore: The US Food and Drug Administration (FDA) has set August 26, 2013, as the date for action on QRxPharma's res...
Melbourne-based bluechiip is a tracking technology company that was listed on the Australia Stock Exchange in June 2011....
Singapore: Analysis from leading healthcare fund manager BioScience Managers has highlighted the outstanding year for bi...
Singapore: The Australian government has joined hands with generics manufacturer Apotex in suing Sanofi Aventis seeking ...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Melbourne-based drug delivery technology company, Phosphagenics, is going to launch phase I study of a transd...
Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...
Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...
Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central aortic blood pressur...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first thera...
Singapore: Ministerial Advisory Committee on HIV/AIDS (MAC) in Australia has achieved 15 percent reduction in HIV notifi...
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Australia Minister for Health, Ms Tanya Plibersek, announced that $652 million will be provided for 1,141 gra...
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system which measures central aor...
Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company A...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
A company that has been leveraging on drug delivery products is Alchemia. Its HyACT technology uses hyaluronic acid's (H...
Singapore: Pfizer will make a phased exit of its West Ryde plant in Australia, which produces tablets and capsules for b...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: AusBiotech has appointed Mr Lawrence Gozlan as a non-executive director to its board. He has experience in gl...
Singapore: Vaxxas, a UniQuest start-up established in 2011 to commercialize the Nanopatch vaccine delivery system based...
Singapore: Dr Deborah Rathjen, managing director of Bionomics and chair of AusBiotech, has been elected as the chair of ...
Singapore: Australian drug delivery company, Phosphagenics, has received regulatory nod to commence proof of concept of ...
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...
Singapore: Scientists at the Walter and Eliza Hall Institute in Melbourne, Australia, have been awarded funding from Can...
Singapore: Australian drug discovery and development company Alchemia reported a record quarterly profit share of $3.5 m...
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...
Singapore: Medical technology company iSonea received approval from Australia's Therapeutic Goods Administration (TGA) t...
Singapore: Australia-based ResMed reported record revenue and income for the quarter ending June 30, 2013. Revenue was $...
Singapore: Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has appoin...
Singapore: Dr Esra Ogru, former chief executive of Phosphagenics has sold her shares in the company to repay $5.7 millio...
Singapore: Bionomics presented data on BNC375, its drug candidate for the treatment of memory loss in Alzheimer's diseas...
Singapore: A study conducted at the University of Louisville, US, has found out the way to create nanoparticles using na...
Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...
Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, ...
Singapore: US-based United Parcel Service (UPS) has expanded its global healthcare distribution facility network in the ...
Singapore: Australia-based Universal Biosensors (UBI) has bagged 'Technology in Manufacturing Award' at Victorian Manufa...
Singapore: Australia's leaing vitamin maker Blackmores recently announced the acquisition of Chinese herbal medicine fir...
Singapore: Menopause doesn't cause women to gain weight, but affects where weight gain occurs, according to the latest ...
Singapore: Scientists in Australia have been studying people, who have developed an immunity to malaria. These scientist...
